We previously developed a tool that identified individuals who later developed esophageal adenocarcinoma (based on age, sex, body mass index, smoking status, and prior esophageal conditions) with an area under the curve of 0.80. In this study, we collected data from 329,463 individuals in the UK Biobank cohort who were tested for genetic susceptibility to esophageal adenocarcinoma (a polygenic risk score based on 18 recognized genetic variants). We found that after inclusion of this genetic information, the area under the curve for identification of individuals who developed esophageal adenocarcinoma remained at 0.80. Testing for genetic variants associated with esophageal adenocarcinoma therefore seems unlikely to improve identification of individuals at risk of esophageal adenocarcinoma.
|Early online date||19 Sep 2018|
|Publication status||Published - 01 Jan 2019|
- Early Detection of Cancer
- oesophageal cancer
FingerprintDive into the research topics of 'Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors'. Together they form a unique fingerprint.
- School of Medicine, Dentistry and Biomedical Sciences - Patrick G. Johnston Fellow
- Centre for Public Health